1959O BL-B01D1, an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic urothelial carcinoma (UC)
D. Ye, Xiu‐Wu Bian, Ting Yang, Shiming Jiang, Min Cao, X. Hua, Songshu Xiao, H. Wang, Huaijun Zhu, Yu Zhu
Topics & Concepts
MedicineMetastatic Urothelial CarcinomaOncologyCancer researchBispecific antibodyConjugateInternal medicineUrothelial carcinomaAntibodyCancerMonoclonal antibodyImmunologyBladder cancerMathematicsMathematical analysisLung Cancer Treatments and MutationsCancer Cells and MetastasisBladder and Urothelial Cancer Treatments